Researchers discover possible new biomarker of MS-like autoimmune disease

It has been known for several years that the diagnosis “multiple sclerosis” conceals a whole range of different illnesses, each requiring customized treatment. Researchers at the University of Basel and the University Hospital of Basel have now described a possible new MS-like disease and explained how to diagnose it.

Health care systems must stop exploiting nurses’ tender hearts and begin supporting them

“Code yellow!” someone screamed. I dipped in and out of consciousness, in and out of panic. advertisement Eighteen years as a nurse myself and I

July 13, 2023

Novel Oral Tx Shows Early Promise in Relapsed/Refractory Myeloma

A novel protein-degrading agent exhibited promising activity in patients with relapsed/refractory multiple myeloma, results of a preliminary clinical trial showed. Among 101 patients who received

August 31, 2023

FDA should embrace new ways of evaluating rare disease drugs, report argues

To increase the pace of rare disease drug approvals, the FDA should embrace nontraditional data, deploy new forms of analysis and be more open about

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.